Clinical Nurse Specialist in Cragsmoor, NY Accepting Medicare
1 Clinical Nurse Specialist nurses found. Showing 1 - 1
 Mr. Stanislaus Dashawetz, ANP Clinical Nurse Specialist - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 236 Cragsmoor Rd, Cragsmoor, NY 12420 Phone: 845-647-7067 |
News Archive
Some patients pay more at Madison clinic to subsidize others
At the Our Lady of Hope Clinic in Madison, Wis., some patients — about half — pay a premium for boutique - or concierge - services, which pays for care for the other half - those without insurance at all. "Now one year old, the clinic started off slowly but is gaining momentum and seems to be a viable business model, clinic officials said. The clinic has 110 paying patients, called benefactors, and serves about two dozen uninsured people weekly."
Stem cell patterns in flies offer potential applications for human biologists
A new study examining the brains of fruit flies reveals a novel stem cell mechanism that may help explain how neurons form in humans. A paper on the study by researchers at the University of Oregon appeared in the online version of the journal Nature in advance of the June 27 publication date.
CARBOGEN AMCIS installs new stability chambers at Switzerland facility
Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has expanded its service portfolio and capacity for stability studies. In compliance with the latest International Conference on Harmonisation (ICH) guidelines, and in response to customer demand, the company has installed new stability chambers at the Hunzenschwil (Neuland), Switzerland operations and offers short-term, long-term, accelerated, intermediate, follow-up and customized tests.
Early initiation of prophylaxis linked to lower rates of PE and DVT in patients with severe brain injuries
People who sustain a traumatic brain injury (TBI) are at high risk for developing deep vein thrombosis (DVT) and pulmonary embolism (PE). PE is a leading cause of death in these patients.
Provectus Pharmaceuticals commences Phase 1 study of PV-10 for liver cancer
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has initiated a Phase 1 study of PV-10 for liver cancer. The study will enroll up to six subjects with cancer metastatic to the liver or with recurrent liver cancer. PV-10 is the company's lead oncology drug candidate that is also currently undergoing Phase 2 study for metastatic melanoma.
› Verified 3 days ago